Galapagos NV
GLPG
#4563
Rank
โ‚น189.74 B
Marketcap
โ‚น2,838
Share price
-0.57%
Change (1 day)
24.35%
Change (1 year)

Galapagos NV (GLPG) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น321.57 Billion

According to Galapagos NV's latest financial reports the company has โ‚น321.57 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galapagos NV - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น278.30 B-17.92%
2023-12-31โ‚น339.07 B-6.69%
2022-12-31โ‚น363.40 B-8.33%
2021-12-31โ‚น396.44 B-14.61%
2020-12-31โ‚น464.29 B0.54%
2019-12-31โ‚น461.80 B347.26%
2018-12-31โ‚น103.25 B17.07%
2017-12-31โ‚น88.19 B26.78%
2016-12-31โ‚น69.56 B181.33%
2015-12-31โ‚น24.72 B70.9%
2014-12-31โ‚น14.46 B22.73%
2013-12-31โ‚น11.78 B71.98%
2012-12-31โ‚น6.85 B206.5%
2011-12-31โ‚น2.23 B-7.11%
2010-12-31โ‚น2.40 B-23.57%
2009-12-31โ‚น3.15 B71.64%
2008-12-31โ‚น1.83 B-35.02%
2007-12-31โ‚น2.82 B-6.18%
2006-12-31โ‚น3.01 B139.15%
2005-12-31โ‚น1.25 B108.58%
2004-12-31โ‚น0.60 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
AstraZeneca
AZN
โ‚น735.04 B 128.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น1.667 T 418.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น938.96 B 191.99%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น509.46 B 58.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
โ‚น6.68 B-97.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น694.70 B 116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น197.90 B-38.46%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น399.26 B 24.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น1.636 T 408.83%๐Ÿ‡บ๐Ÿ‡ธ USA